252 related articles for article (PubMed ID: 16476686)
61. Safety assurances for dietary supplements policy issues and new research paradigms.
Basch EM; Servoss JC; Tedrow UB
J Herb Pharmacother; 2005; 5(1):3-15. PubMed ID: 16093231
[TBL] [Abstract][Full Text] [Related]
62. Amended final report on the safety assessment of Oryza Sativa (rice) Bran Oil, Oryza Sativa (rice) Germ Oil, Rice Bran Acid,Oryza Sativa (rice) Bran Wax, Hydrogenated Rice Bran Wax, Oryza Sativa (rice)Bran Extract, Oryza Sativa (rice) Extract, Oryza Sativa (rice) Germ Powder, Oryza Sativa (rice) Starch, Oryza Sativa (rice) Bran, Hydrolyzed Rice Bran Extract, Hydrolyzed Rice Bran Protein, Hydrolyzed Rice Extract, and Hydrolyzed Rice Protein.
Int J Toxicol; 2006; 25 Suppl 2():91-120. PubMed ID: 17090480
[TBL] [Abstract][Full Text] [Related]
63. Nanotechnology and dermatology: part I--potential of nanotechnology.
Nasir A
Clin Dermatol; 2010; 28(4):458-66. PubMed ID: 20620764
[No Abstract] [Full Text] [Related]
64. United States Government Accountability Office report on nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk.
United States Government Accountability Office
Int J Occup Environ Health; 2010; 16(4):525-39. PubMed ID: 21222394
[TBL] [Abstract][Full Text] [Related]
65. Amended final report of the safety assessment of Drometrizole as used in cosmetics.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():63-75. PubMed ID: 18569163
[TBL] [Abstract][Full Text] [Related]
66. Final report of the amended safety assessment of PEG-5, -10, -16, -25, -30, and -40 soy sterol.
Int J Toxicol; 2004; 23 Suppl 2():23-47. PubMed ID: 15513823
[TBL] [Abstract][Full Text] [Related]
67. Nanomaterials in the construction industry: a review of their applications and environmental health and safety considerations.
Lee J; Mahendra S; Alvarez PJ
ACS Nano; 2010 Jul; 4(7):3580-90. PubMed ID: 20695513
[TBL] [Abstract][Full Text] [Related]
68. Potential release scenarios for carbon nanotubes used in composites.
Nowack B; David RM; Fissan H; Morris H; Shatkin JA; Stintz M; Zepp R; Brouwer D
Environ Int; 2013 Sep; 59():1-11. PubMed ID: 23708563
[TBL] [Abstract][Full Text] [Related]
69. Nanotechnology in cosmetics: Opportunities and challenges.
Raj S; Jose S; Sumod US; Sabitha M
J Pharm Bioallied Sci; 2012 Jul; 4(3):186-93. PubMed ID: 22923959
[TBL] [Abstract][Full Text] [Related]
70. Nanomaterials: a challenge for toxicological risk assessment?
Haase A; Tentschert J; Luch A
Exp Suppl; 2012; 101():219-50. PubMed ID: 22945571
[TBL] [Abstract][Full Text] [Related]
71. Development of a consumer product ingredient database for chemical exposure screening and prioritization.
Goldsmith MR; Grulke CM; Brooks RD; Transue TR; Tan YM; Frame A; Egeghy PP; Edwards R; Chang DT; Tornero-Velez R; Isaacs K; Wang A; Johnson J; Holm K; Reich M; Mitchell J; Vallero DA; Phillips L; Phillips M; Wambaugh JF; Judson RS; Buckley TJ; Dary CC
Food Chem Toxicol; 2014 Mar; 65():269-79. PubMed ID: 24374094
[TBL] [Abstract][Full Text] [Related]
72. Nanotechnology: the challenge of regulating known unknowns.
Wilson RF
J Law Med Ethics; 2006; 34(4):704-13. PubMed ID: 17199812
[TBL] [Abstract][Full Text] [Related]
73. Photonanodermatology: the interface of photobiology, dermatology and nanotechnology.
Hia J; Nasir A
Photodermatol Photoimmunol Photomed; 2011 Feb; 27(1):2-9. PubMed ID: 21198876
[TBL] [Abstract][Full Text] [Related]
74. Emerging nanomaterial governance systems: the state of play.
Bergeson LL
Mol Imaging; 2011 Feb; 10(1):17-27. PubMed ID: 21303612
[TBL] [Abstract][Full Text] [Related]
75. Categorization framework to aid exposure assessment of nanomaterials in consumer products.
Hansen SF; Michelson ES; Kamper A; Borling P; Stuer-Lauridsen F; Baun A
Ecotoxicology; 2008 Jul; 17(5):438-47. PubMed ID: 18454314
[TBL] [Abstract][Full Text] [Related]
76. Nanomaterials in Cosmetics: Recent Updates.
Fytianos G; Rahdar A; Kyzas GZ
Nanomaterials (Basel); 2020 May; 10(5):. PubMed ID: 32443655
[TBL] [Abstract][Full Text] [Related]
77. Release of nanomaterials from solid nanocomposites and consumer exposure assessment - a forward-looking review.
Mackevica A; Foss Hansen S
Nanotoxicology; 2016 Aug; 10(6):641-53. PubMed ID: 26667577
[TBL] [Abstract][Full Text] [Related]
78. Advances in Nanotechnology as They Pertain to Food and Agriculture: Benefits and Risks.
Sadeghi R; Rodriguez RJ; Yao Y; Kokini JL
Annu Rev Food Sci Technol; 2017 Feb; 8():467-492. PubMed ID: 28125343
[TBL] [Abstract][Full Text] [Related]
79. A model for screening and prioritizing consumer nanoproduct risks: A case study from South Africa.
Musee N
Environ Int; 2017 Mar; 100():121-131. PubMed ID: 28089582
[TBL] [Abstract][Full Text] [Related]
80. Risk assessment of low-level chemical exposures from consumer products under the U.S. Consumer Product Safety Commission chronic hazard guidelines.
Babich MA
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):387-90. PubMed ID: 9539035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
